Thrombocytapheresis in Patient with Essential Thrombocythemia: A Case Report

Afra M Elhassan; Arwa Alsaud; Mohamed A Yassin; Mahmood Aldapt; Lubna Riaz; Firdous Ghori; Aiman Bin Ahmad; Mohammad Abdulla

doi:10.1159/000507651

Thrombocytapheresis in Patient with Essential Thrombocythemia: A Case Report

Case Rep Oncol. 2020 Jun 16;13(2):675-679. doi: 10.1159/000507651. eCollection 2020 May-Aug.

Authors

Afra M Elhassan¹, Arwa Alsaud¹, Mohamed A Yassin², Mahmood Aldapt², Lubna Riaz², Firdous Ghori², Aiman Bin Ahmad², Mohammad Abdulla²

Affiliations

¹ Department of Internal Medicine, Hamad Medical Corporation, Doha, Qatar.
² National Centre for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.

Abstract

Essential thrombocythemia (ET) is one of the myeloproliferative neoplasms, characterized by persistent thrombocytosis, platelets >450,000/μL, and evident clonal abnormalities like JAK2 V617F, MPL, CALR mutation and not fulfilling WHO criteria for MDS, CML, PV, and IDA. Here we report a 24-year-old female who presented with headache and was found to have thrombocytosis with a platelet count of 2,141 × 10³/μL, diagnosed as ET as per WHO criteria 2008; she required ICU admission and thrombocytapheresis with a favorable outcome.

Keywords: Essential thrombocythemia; Platelet; Plateletpheresis; Thrombocytapheresis; Thrombocytosis.

Publication types

Case Reports